Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y C Ahn

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|July 3, 2008
ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiationH J Jun, M J Ahn, H S Kim, et al.
Cancer Research and Treatment|December 19, 2015
Combined Chemotherapy and Radiotherapy for Primary CNS LymphomaJ E Lee, D Y Kim, Y C Ahn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2009
When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?S J Kim, S Y Oh, J Y Hong, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2015
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancerS H Lim, M Hong, S Ahn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?W S Kim, S Y Song, Y C Ahn, et al.
British Journal of Cancer|June 27, 2007
A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future managementH-S Lee, S T Kim, J Lee, et al.
ESMO Open|February 14, 2022
Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II studyS Park, J-M Sun, Y-L Choi, et al.
Acta Oncologica (Stockholm, Sweden)|October 24, 2001
Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancerY C Ahn, K Park, D Y Kim, et al.
British Journal of Cancer|March 31, 2005
Nasal-type NK/T cell lymphoma: clinical features and treatment outcomeJ Lee, W S Kim, Y H Park, et al.
Japanese Journal of Clinical Oncology|February 24, 2001
A phase II study of VP-16-fosfamide-cisplatin combination chemotherapy plus early concurrent thoracic irradiation for previously untreated limited small cell lung cancerI S Woo, Y S Park, S H Kwon, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|July 3, 2008
ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiationH J Jun, M J Ahn, H S Kim, et al.
Cancer Research and Treatment|December 19, 2015
Combined Chemotherapy and Radiotherapy for Primary CNS LymphomaJ E Lee, D Y Kim, Y C Ahn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2009
When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?S J Kim, S Y Oh, J Y Hong, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2015
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancerS H Lim, M Hong, S Ahn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?W S Kim, S Y Song, Y C Ahn, et al.
British Journal of Cancer|June 27, 2007
A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future managementH-S Lee, S T Kim, J Lee, et al.
ESMO Open|February 14, 2022
Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II studyS Park, J-M Sun, Y-L Choi, et al.
Acta Oncologica (Stockholm, Sweden)|October 24, 2001
Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancerY C Ahn, K Park, D Y Kim, et al.
British Journal of Cancer|March 31, 2005
Nasal-type NK/T cell lymphoma: clinical features and treatment outcomeJ Lee, W S Kim, Y H Park, et al.
Japanese Journal of Clinical Oncology|February 24, 2001
A phase II study of VP-16-fosfamide-cisplatin combination chemotherapy plus early concurrent thoracic irradiation for previously untreated limited small cell lung cancerI S Woo, Y S Park, S H Kwon, et al.
Pageof 4